Discover 925 paid clinical trials in Hillsboro, Oregon. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 925
Study of Arlocabtagene Autoleucel (BMS-986393) a GPRC5D-directed CAR T Cell Therapy in Adult Participants With Relapsed or Refractory Multiple Myeloma
for
Multiple Myeloma
Location: Portland OR, Seattle WA, San Francisco CA, Calgary,
Sponsor: Juno Therapeutics, Inc., a Bristol-Myers Squibb Company
Sex: All
Age: 18+
Code: NCT06297226
Phase 2, Recruiting
A Study of SGT-003 Gene Therapy in Duchenne Muscular Dystrophy (INSPIRE DUCHENNE)
for
Duchenne Muscular Dystrophy
Location: Portland OR, Seattle WA, Sacramento CA, Los Angeles CA,
Sponsor: Solid Biosciences Inc.
Sex: Male
Age: 0 - 17
Code: NCT06138639
Phase 1, Phase 2, Recruiting
Treatment of the Biceps With Concomitant Supraspinatus Tears
for
Supraspinatus Tear
Location: Portland OR, Calgary, Ann Arbor MI
Sponsor: La Tour Hospital
Sex: All
Age: 50 - 70+
Code: NCT05660031
Recruiting
A Non-interventional, Post-authorisation Safety Study of Patients Treated With Efgartigimod Alfa
for
Myasthenia Gravis
Location: Portland OR, San Francisco CA, Kansas City KS,
Sponsor: argenx
Sex: All
Age: 18+
Code: NCT06298565
Recruiting
A Study to Evaluate Axatilimab and Corticosteroids as Initial Treatment for Chronic Graft-Versus-Host Disease
for
Chronic Graft-versus-host-disease
Location: Portland OR, Vancouver, San Francisco CA, Calgary,
Sponsor: Incyte Corporation
Sex: All
Age: 12+
Code: NCT06585774
Phase 3, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
A Study of Enzalutamide Plus the Glucocorticoid Receptor Antagonist Relacorilant Versus Placebo for Patients With High-risk Localized Prostate Cancer
for
Prostate Cancer, Prostate Adenocarcinoma
Location: Portland OR, Dallas TX, Chicago IL
Sponsor: University of Chicago
Sex: Male
Age: 18+
Code: NCT05726292
Phase 2, Recruiting
A Study of JNJ-87189401 Combined With JNJ-78278343 for Advanced Prostate Cancer